These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 4012803)

  • 21. Early nifurtimox-induced biochemical and ultrastructural alterations in rat heart.
    Bartel LC; Montalto de Mecca M; Fanelli SL; Rodriguez de Castro C; Diaz EG; Castro JA
    Hum Exp Toxicol; 2007 Oct; 26(10):781-8. PubMed ID: 18025049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
    Filardi LS; Brener Z
    Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of genotoxic activity in the blood and urine of guinea pigs treated with nifurtimox and benznidazole.
    Ferreira RC; de Melo ME; Moraes Júnior MA; Ferreira LC
    Braz J Med Biol Res; 1988; 21(5):1069-77. PubMed ID: 3248236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Species and sex differences in the liver microsomal nitroreductive biotransformation of nifurtimox and benznidazole.
    Aguilar EG; Koldobsky C; de Toranzo EG; Castro JA
    Arch Int Pharmacodyn Ther; 1987 Jun; 287(2):181-7. PubMed ID: 3632141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Different effects of nifurtimox and benznidazole on the biosynthesis of DNA, RNA and proteins in Trypanosoma cruzi].
    Goijman SG; Frasch AC; Stoppani AO
    Medicina (B Aires); 1984; 44(3):261-70. PubMed ID: 6085847
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of complement mediated lysis technic in patients with chronic Chagas' disease treated with trypanocidal drugs].
    Levy AM; Pereira VL; Boainain E
    Rev Inst Med Trop Sao Paulo; 1988; 30(1):32-9. PubMed ID: 3146793
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of Chagas' disease].
    Apt W
    Rev Med Chil; 1985 Feb; 113(2):162-6. PubMed ID: 3936147
    [No Abstract]   [Full Text] [Related]  

  • 28. Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail.
    Crespillo-Andújar C; Chamorro-Tojeiro S; Norman F; Monge-Maillo B; López-Vélez R; Pérez-Molina JA
    Clin Microbiol Infect; 2018 Dec; 24(12):1344.e1-1344.e4. PubMed ID: 29906591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The anticlastogenic effect of tocopherol in peritoneal macrophages of benznidazole-treated and ovariectomized mice.
    Lacava ZG; Luna H
    Mutat Res; 1994 Mar; 305(2):145-50. PubMed ID: 7510024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of trypanocidal drugs on protein biosynthesis in vitro and in vivo by Trypanosoma cruzi.
    Gonzalez NS; Cazzulo JJ
    Biochem Pharmacol; 1989 Sep; 38(17):2873-7. PubMed ID: 2673249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitroreduction of benznidazole and nifurtimox by rat and human feces.
    de Toranzo EG; Masana M; Castro JA
    Res Commun Chem Pathol Pharmacol; 1983 Aug; 41(2):341-4. PubMed ID: 6688884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nifurtimox therapy for Chagas disease does not cause hypersensitivity reactions in patients with such previous adverse reactions during benznidazole treatment.
    Pérez-Molina JA; Sojo-Dorado J; Norman F; Monge-Maillo B; Díaz-Menéndez M; Albajar-Viñas P; López-Vélez R
    Acta Trop; 2013 Aug; 127(2):101-4. PubMed ID: 23583863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas' disease).
    Castro JA; Diaz de Toranzo EG
    Biomed Environ Sci; 1988 Jun; 1(1):19-33. PubMed ID: 3151755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thirteenfold increase of chromosomal aberrations non-randomly distributed in chagasic children treated with nifurtimox.
    Gorla NB; Ledesma OS; Barbieri GP; Larripa IB
    Mutat Res; 1989 Oct; 224(2):263-7. PubMed ID: 2507913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First century of Chagas' disease: an overview on novel approaches to nifurtimox and benzonidazole delivery systems.
    Salomon CJ
    J Pharm Sci; 2012 Mar; 101(3):888-94. PubMed ID: 22161779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benznidazole and nifurtimox nitroreductase activity in liver microsomes from male rats preinduced with phenobarbital or 3-methylcholanthrene.
    Aguilar EG; de Arranz CK; de Toranzo EG; Castro JA
    Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):443-6. PubMed ID: 3841223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic side effects of drugs used to treat Chagas' disease (American trypanosomiasis).
    Castro JA; de Mecca MM; Bartel LC
    Hum Exp Toxicol; 2006 Aug; 25(8):471-9. PubMed ID: 16937919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness).
    Tweats D; Bourdin Trunz B; Torreele E
    Mutagenesis; 2012 Sep; 27(5):523-32. PubMed ID: 22539226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole.
    López-Muñoz R; Faúndez M; Klein S; Escanilla S; Torres G; Lee-Liu D; Ferreira J; Kemmerling U; Orellana M; Morello A; Ferreira A; Maya JD
    Exp Parasitol; 2010 Feb; 124(2):167-71. PubMed ID: 19735656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease.
    Gallerano RH; Marr JJ; Sosa RR
    Am J Trop Med Hyg; 1990 Aug; 43(2):159-66. PubMed ID: 2117857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.